Global Circular RNA Research Market Research Report 2023

Circular RNA is a type of single-stranded RNA molecule with a special structure, which widely exists in different organisms. Unlike the classic linear RNA (linear RNA), circular RNA molecules have no 5' and 3' ends and are in a closed circular structure. Therefore it is not affected by RNA exonucleases and is more stable in vivo. It is a popular target for the treatment of human diseases. Its application potential is very great, and it has opened up a new idea for the field of biomedicine. Circular RNAs with clear functions can be used not only as biomarkers for the diagnosis of certain diseases, but also as therapeutic targets for some important diseases, especially immune diseases and cancers. They are widely used in infectious diseases, rare diseases, The treatment of blood diseases and tumors has both research and application value.

According to Researcher's new survey, global Circular RNA Research market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Circular RNA Research market research.

Key companies engaged in the Circular RNA Research industry include Laronde, Orna Therapeutics, Chimerna Therapeutics, Shanghai Circode, Therorna Inc., Beijing Abace Biology, BGI TechSolutions Co.,Ltd. (BGI-Tech), Shanghai Cloudseq and Guangzhou Geneseed Biotech Co.,Ltd., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Circular RNA Research were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Circular RNA Research market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Circular RNA Research market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Laronde

Orna Therapeutics

Chimerna Therapeutics

Shanghai Circode

Therorna Inc.

Beijing Abace Biology

BGI TechSolutions Co.,Ltd. (BGI-Tech)

Shanghai Cloudseq

Guangzhou Geneseed Biotech Co.,Ltd.



Segment by Type


ecircRNA Research

ciRNA Research

ElciRNA Research

Other



Segment by Application


Research & Academic Institutes

Pharma & Biotech Companies

CROs


By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

The Circular RNA Research report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Global market size, regional market size. Market Opportunities and Challenges

Chapter 3: Companies’ Competition Patterns

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6 to 10: Country Level Value Analysis

Chapter 11: Companies’ Outline

Chapter 12: Market Conclusions

Chapter 13: Research Methodology and Data Source